Skip to main content
Clinical Trials/NCT02853682
NCT02853682CompletedNot Applicable

Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery

Centre Hospitalier Universitaire, Amiens1 site in 1 country28 target enrollmentStarted: January 20, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
1
Primary Endpoint
glycocalyx proteins 1

Study Overview

Brief Summary

The glycocalyx is a layer of proteins and complex sugars covering the endothelium of vessels. Its role as capillary filtration control is important. In case of alteration of the glycocalyx, experimental models and some clinical studies show an increased capillary leak responsible for interstitial edema. The analysis of glycocalyx in routine care is important to guide volume expansion. Indeed, the literature provides evidence about the poor prognosis of excess water and its impact on organ. This analysis challenge is to justify filling solution of choice according to the characteristic of this capillary leakage.

Detailed Description

Extra corporeal circulation and aortic clamp induce ischemia-reperfusion damages.

Vascular damages are represented by first glycocalyx, a layer of endovascular vessel proteoglycans, responsible for fluid permeability and secondly by nitro oxygen liberation responsible for vascular tonus.

The investigators suppose that both functions are impaired after cardiac surgery.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •cardiac surgery

Exclusion Criteria

  • •auricular fibrillation
  • •endocarditis
  • •aortic dissection
  • •end stage chronic renal disease

Arms & Interventions

absence of vascular dysfunction

plasma

Intervention: plasma (Biological)

presence of a vascular dysfunction

plasma

Intervention: plasma (Biological)

Outcomes

Primary Outcomes

glycocalyx proteins 1

Time Frame: 48 hours

proteoglycan in patient plasma is assayed.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials